secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABBOTT LABORATORIES (ABT)
CIK:        0000001800
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001628280-23-034544
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abbott Q3 adj EPS $1.14, rev $10.1B; raises FY23 EPS midpoint
-------------------------------------------------------------

- Q3 GAAP EPS $0.82; adjusted EPS $1.14; reported sales $10.1B (-2.6% YoY).
- Organic base-business sales (ex-COVID tests) up 13.8%; double-digit growth in all four segments.
- Full-year 2023 adjusted EPS guidance raised to $4.42–$4.46 (midpoint $4.44 vs prior $4.30–$4.50).
- Medical Devices organic growth 14.7%; FreeStyle Libre sales $1.4B (+28.5% organic).
- Quarterly dividend maintained at $0.51/share; 399th consecutive quarterly payout.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800/000162828023034544/0001628280-23-034544-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800/000162828023034544/abt-20231018.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034544

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer